B+
Bull case
0%
Probability
Target price
$24.00
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
SHC
Sotera HealthBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Raised outlook, high-single-digit growth, strong Sterigenics and Nordion execution, improved liquidity, and leverage reaching the company's 2.0x-3.0x target range support upside if performance persists [#SEC-8K-2026-08-06].
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -3.9.
What can break
Nelson Labs six-month segment income declined 4.9%, with higher costs affecting margins [#SEC-8K-2026-08-06].
Momentum
61
Value
64
Sentiment
67
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $19.50 · Bull $24.00 · Bear $15.50Analysis 2026-08-08; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-08 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-18
Investment thesis
As of 2026-09-18
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-18. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $22.72
Why
Momentum61 · Δ7d +4.5
Value64 · Δ7d +0.0
Sentiment67 · Δ7d -3.9
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta -3.9.
Contradictions & invalidation
- • Nelson Labs six-month segment income declined 4.9%, with higher costs affecting margins [#SEC-8K-2026-08-06].
- • Nordion's strong quarterly growth was partly driven by the timing of Cobalt-60 harvests and may be less repeatable [#SEC-8K-2026-08-06].
- • The positive print may not translate into sustained upside if Nordion's timing benefit normalizes, Nelson Labs cost pressure persists, or leverage remains elevated.
Catalyst clock
2026-08-06
Strong Q2 with raised FY2026 outlook
Lead driver: Sentiment · See AI snapshot
Momentum
61
9% active weight
Current posture
7d trendImproving
Δ7d
+4.5
Δ21d
-7.8
Value
64
28% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.0
Sentiment
67
62% active weight
Current posture
7d trendSoftening
Δ7d
-3.9
Δ21d
+4.6
Why this grade
Composite grade B. Momentum 61.2 / Value 63.6 / Sentiment 66.8
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-08. Scenario method
Most likely
B
Base case
0%
Probability
Target price
$19.50
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
B-
Bear case
0%
Probability
Target price
$15.50
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$5.37B
Beta
1.82
Shares Out
285.38M
P/E (TTM)
94.8
P/S (TTM)
4.52
P/FCF (TTM)
60.02
Rev YoY
+9.2%
EPS YoY
+567.4%
Gross Margin
+54.0%
Op Margin
+36.9%
Net Debt
$1.93B
Current Ratio
2.80
As of 2026-09-18 • Updated nightlySource: Internal modelMethods & Data